Indivior PLC (LON:INDV)‘s stock had its “buy” rating restated by research analysts at Stifel Nicolaus in a report issued on Friday. They presently have a GBX 500 ($6.24) price target on the specialty pharmaceutical company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 58.78% from the company’s current price. A number of other […]
